当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第19期
编号:12961471
不同来源的细胞因子诱导的杀伤细胞体外抗肿瘤作用的比较研究(5)
http://www.100md.com 2016年7月5日 《中国现代医生》 2016年第19期
     [11] Wang QJ,Wang H,Pan K,et al. Comparative study on anti-tumor immune response of autologous cytokine-induced killer(CIK) cells,dendritic cells-CIK(DC-CIK),and semi-allogeneic DC-CIK[J]. C hin J Cancer,2010, 29(7):641-648.

    [12] Pan Y,Wu Y,Ji J,et al. Effect of cytokine-induced killer cells on immune function in patients with lung cancer[J]. Oncol Lett,2016, 11(4):2827-2834.

    [13] Zhang J,Zhu L,Du H,et al. Autologous cytokine-induced killer cell therapy in lung cancer patients:A retrospective study[J]. Biomed Pharmacother,2015,70:248-252.

    [14] Liu H,Li J,Wang F,et al. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma[J]. Tumour Biol,2015, 36(4):2299-2307.

    [15] Wang M,Cao JX,Pan JH,et al. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer[J]. PLoS One,2014,9(11):e112662.

    [16] Betts MR,Brenchley JM,Price DA,et al. Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation[J]. J Immunol Methods,2003,281(1-2): 65-78.

    [17] 刘垠子,罗以,谢思琪,等. DC-CIK 的抗肿瘤作用及机制的研究进展[J]. 肿瘤药学,2016,6(2):108-113.

    (收稿日期:2016-05-26), 百拇医药(于鸿 张耿月 魏天雪 何春莹 刘玉侠)
上一页1 2 3 4 5